论文部分内容阅读
目的探索介入联合服用加味四逆泻心汤治疗进展期胃癌的疗效。方法将临床收治的符合入组条件的进展期胃癌患者60例随机分为两组,对照组(30例)单纯采用介入治疗,化疗用药为5-Fu 0.5g/m~2,表柔比星20-40 mg,奥沙利铂130 mg/m~2;观察组(30例)则在对照组的基础上联合服用加味四逆泻心汤。比较两组患者的临床疗效。结果对照组临床有效率为53.4%,处理组为86.2%,两组相比差异有统计学意义(P<0.05)。;介入治疗后评价卡氏评分处理组(85.10±6.37)高于对照组(79.04+±8.53),有统计学差异(P<0.05);在消化道不良反应,血细胞减少,肝肾功能损害等方面,观察组与对照组相比差异无统计学意义(P>0.05)。结论介入联合加味四逆泻心汤治疗进展期胃癌疗效较好,值得临床进一步推广和研究。
Objective To explore the efficacy of Jiawei Sini xinxin decoction in the treatment of advanced gastric cancer. Methods Sixty patients with advanced gastric cancer who were admitted to our hospital were randomly divided into two groups. The control group (30 cases) was treated with 5-Fu 0.5 g / m ~ 2, while the epirubicin 20-40 mg, oxaliplatin 130 mg / m ~ 2; observation group (30 cases) in the control group based on the combination of Modified Sini Xie Xin Tang. The clinical efficacy of the two groups was compared. Results The clinical effective rate was 53.4% in the control group and 86.2% in the treated group. There was significant difference between the two groups (P <0.05). (85.10 ± 6.37) after interventional treatment was significantly higher than that of the control group (79.04 ± 8.53) (P <0.05). In the adverse reactions of gastrointestinal tract, cytopenia, liver and kidney dysfunction, etc. There was no significant difference between observation group and control group (P> 0.05). Conclusions Interventional joint flavored Sini xin xin decoction is effective in treating advanced gastric cancer and deserves to be further popularized and studied clinically.